Close
Reports within 10-14 days
A safe and simple blood test during pregnancy
Non-Invasive Prenatal Testing (NIPT) is an advanced screening test performed using a small sample of the mother’s blood to assess the risk of certain chromosomal conditions in the baby. It is completely safe, non-invasive, and poses no risk to both mother and fetus. This test is recommended between 10 to 14 weeks of pregnancy, allowing early and reliable insights for informed decision-making.
Report Time: Approximately 10-14 days
Gender determination may be limited in twins or triplet pregnancies
Most commonly: -Basic Panel
Down syndrome (Trisomy 21)*
Edwards syndrome (Trisomy 18)*
Patau syndrome (Trisomy 13)*
Advanced panels may also screen for:
Selected microdeletions
Yes — completely safe:
Requires only a simple blood draw from the mother
No risk to the baby (unlike invasive tests)
Yes (both Basic and Extended)
It can detect fetal sex chromosomes easily in single uterine babies (some limitations in multiple pregnancies)
Often highly accurate.
10 to 14 days
At Accuracy Plus, we create a scientific, all-inclusive, and value-adding diagnostic culture of excellent, timely test results conforming to world-class testing standards and benchmarks for swifter and better disease detection.
© COPYRIGHT 2025 -ACCURACY PLUS - ALL RIGHTS RESERVED
